Australia's place in the vaccine queue

More and more COVID-19 vaccines are returning their clinical results, and it's good news. The latest development came from the Oxford University trial with pharmaceutical company Astrazeneca, which was found to be 70% effective in participants, although that figure rose to 90% when the vaccine was administered in a different dose. It comes hot on the heels of two other vaccine candidates returning preliminary results of 95% efficacy earlier in November. In fact the recent results have been so promising the US, the UK and Germany are weeks away from starting to roll out vaccines to the public. So what's the hold up in Australia? Today on The Signal, Australia's place in the vaccine queue. And how will the rollout go when it does happen? Featured: Professor Terry Nolan, Head of the Vaccine and Immunisation Research Group, Peter Doherty Institute, University of Melbourne